A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.

about

A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo.

Item

http://www.wikidata.org/entity/Q40142694

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A common anti-cytomegalovirus ...... tion in human tissues ex vivo.

@en

type

Item

label

A common anti-cytomegalovirus ...... tion in human tissues ex vivo.

@en

prefLabel

A common anti-cytomegalovirus ...... tion in human tissues ex vivo.

@en

P1476

A common anti-cytomegalovirus ...... tion in human tissues ex vivo.

@en

P2093

Andrea Lisco

http://www.w3.org/2001/XMLSchema#string

Anush Arakelyan

http://www.w3.org/2001/XMLSchema#string

Christophe Vanpouille

http://www.w3.org/2001/XMLSchema#string

Elisa Saba

http://www.w3.org/2001/XMLSchema#string

Jean A Bernatchez

http://www.w3.org/2001/XMLSchema#string

Leonid Margolis

http://www.w3.org/2001/XMLSchema#string

Matthias Götte

http://www.w3.org/2001/XMLSchema#string

P2860

Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection

The Sordid Affair Between Human Herpesvirus and HIV

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation.

Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease.

Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment.

Residual immune dysregulation syndrome in treated HIV infection.

P304

1519-1528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001532

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28657962

http://www.w3.org/2001/XMLSchema#string

P932

5541768

http://www.w3.org/2001/XMLSchema#string